Interstitial pneumonitis associated with combined regimen of immunotherapy and conventional therapies—pharmacovigilance database analysis with real-world data validation
2023 · BMC Medicine · 19 citations
https://doi.org/10.1186/s12916-022-02713-6
X
Xiao-Ting Cai
Nanfang Hospital(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
66
Papers
267
Citations
10
h-index
11
i10-index
Xiao-Ting Cai is an academic researcher from Nanfang Hospital. The author has contributed to research in topics: PARP inhibition in cancer therapy & Cancer Immunotherapy and Biomarkers & DNA Repair Mechanisms. The author has an h-index of 10, co-authored 57 publications.
ORCID: 0000-0001-9989-3571Papers by this author
worksOrgan-specific metastatic landscape dissects PD-(L)1 blockade efficacy in advanced non-small cell lung cancer: applicability from clinical trials to real-world practice
2022 · BMC Medicine · 18 citations
https://doi.org/10.1186/s12916-022-02315-2
Assessment of anti-PD-(L)1 for patients with coexisting malignant tumor and tuberculosis classified by active, latent, and obsolete stage
2021 · BMC Medicine · 12 citations
https://doi.org/10.1186/s12916-021-02194-z
Assessment for bone health in patients with differentiated thyroid carcinoma after postoperative thyroid-stimulating hormone suppression therapy: a new fracture risk assessment algorithm
2023 · Frontiers in Endocrinology · 3 citations
https://doi.org/10.3389/fendo.2023.1286947
HLA diversity unveils susceptibility and organ-specific occurrence of second primary cancers: a prospective cohort study
2024 · BMC Medicine · 1 citations
https://doi.org/10.1186/s12916-024-03676-6
Additional file 2 of Assessment of anti-PD-(L)1 for patients with coexisting malignant tumor and tuberculosis classified by active, latent, and obsolete stage
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.17292868
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat